サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1373929

気管支拡張症治療薬市場：薬剤クラス別、投与経路別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）

Bronchiectasis Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 306 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
気管支拡張症治療薬市場：薬剤クラス別、投与経路別、流通チャネル別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023～2030年）
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 306 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の気管支拡張症治療薬の市場規模は、2022年に4億8,171万米ドルとなり、2023年から2030年にかけてCAGRで5.1%の拡大が予測されています。

気管支拡張症治療薬市場 - 市場ダイナミクス

過小診断されがちな気管支拡張症に対する認識の高まりが市場需要を促進

医学的知識と診断能力の進歩により、気管支拡張症患者の特定が増加しています。加えて、人口動態の高齢化と慢性呼吸器疾患の急増が、より効果的な治療ソリューションへの需要を高めています。このような意識の高まりと患者数の増加により、製薬会社や研究者は気管支拡張症を管理するための強化された戦略の開発にリソースを割くようになっています。こうした努力の原動力となっているのは、気管支拡張症患者の幸福を向上させるとともに、再発する感染症や関連症状の負担を軽減するというコミットメントです。

気管支拡張症治療薬市場 - 主な洞察

当社のリサーチアナリストが提供した洞察によると、気管支拡張症治療薬の世界市場は、2023年から2030年までの予測期間を通じて、およそ5.1%の年間成長率が見込まれています。

気管支拡張症治療薬の分野は、主に、しばしば発見されない病状に対する認識の高まりによって、大幅な拡大が見込まれています。

薬剤クラス別では、2022年には抗生物質が市場を独占すると予測されています。

投与経路別では、経口薬が2022年の主要カテゴリーに浮上しました。

地域別では、北米が2022年の売上高でリードしています。

気管支拡張症治療薬市場 - セグメンテーション分析：

気管支拡張症治療薬の世界市場は、薬剤クラス別、投与経路別、流通チャネル別、地域別などの主要要因によって構成されています。

薬剤クラス別では、この市場は4つの明確なセグメントに分類される：抗生物質、粘液溶解剤、気管支拡張剤、抗炎症剤です。注目すべきは、抗生物質がこの分類でリードしていることです。気管支拡張症治療における抗生物質の重要性は、気管支拡張症に伴う一般的な合併症である肺感染症を管理し、再発を予防する役割にあります。抗生物質は、これらの感染症の原因となる微生物を標的として駆除し、最終的には患者の症状、肺機能、全体的なQOLの改善につながります。

気管支拡張症治療薬市場 - 地理的洞察

地理的な観点から、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域にまたがっています。これらの地域内では、個々の国がビジネスの原動力として極めて重要な役割を果たしています。

北米における気管支拡張症治療薬の需要の高まりは、いくつかの要因に集約されています。第一に、同地域の高齢化が進み、気管支拡張症を含む慢性呼吸器疾患に罹患しやすくなっています。第二に、診断の専門知識とヘルスケア従事者の知識の進歩により、より正確でタイムリーな診断が可能となり、これらの薬剤の需要に大きく寄与しています。

気管支拡張症医薬品市場 - 競合情勢：

気管支拡張症治療薬市場は、この疾患に対して承認された専門的治療薬の選択肢が限られていることが特徴です。大手製薬会社は主要な治療選択肢のいくつかを提供しています。とはいえ、専門的な治療薬という点ではやや限定的で、主に再利用された抗生物質、気管支拡張薬、粘液溶解薬に頼っています。気管支拡張症の根本原因に対処し、患者の予後を改善するための革新的な治療法を企業が模索しているためです。このことは、この分野における成長と進歩の有望な展望を提示しています。

目次

第1章 気管支拡張症治療薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 気管支拡張症治療薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 気管支拡張症治療薬業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 気管支拡張症治療薬市場：COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 気管支拡張症治療薬市場情勢

  • 気管支拡張症治療薬市場シェア分析、2022年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 気管支拡張症治療薬市場 - 薬剤クラス別

  • 概要
    • 薬剤クラス別セグメントシェア分析
    • 抗生物質
    • 粘液溶解薬
    • 気管支拡張薬
    • 抗炎症剤

第8章 気管支拡張症治療薬市場 - 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 経口
    • 吸入
    • 静脈内

第9章 気管支拡張症治療薬市場 - 流通チャネル別

  • 概要
    • 流通チャネル別セグメントシェア分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第10章 気管支拡張症治療薬市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 気管支拡張症治療薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • GlaxoSmithKline plc
    • Novartis AG
    • Pfizer Inc.
    • AstraZeneca plc
    • Boehringer Ingelheim International GmbH
    • Roche Holding AG
    • Teva Pharmaceutical Industries Ltd.
    • Bayer AG
    • Sanofi SA
    • Sunovion Pharmaceuticals Inc.
    • Mylan NV
    • Cipla Ltd.
    • Grifols SA
    • Insmed Incorporated
    • Arbor Pharmaceuticals LLC

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Route of Administrations
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bronchiectasis Drugs Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Bronchiectasis Drugs Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Bronchiectasis Drugs Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Bronchiectasis Drugs Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Bronchiectasis Drugs Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Bronchiectasis Drugs Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Bronchiectasis Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bronchiectasis Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bronchiectasis Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bronchiectasis Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bronchiectasis Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bronchiectasis Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Bronchiectasis Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Class segment market share analysis, 2022 & 2030
  • FIGURE Drug Class segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Bronchiectasis Drugs Market share and leading players, 2022
  • FIGURE Europe Bronchiectasis Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Bronchiectasis Drugs Market share and leading players, 2022
  • FIGURE Latin America Bronchiectasis Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Bronchiectasis Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Bronchiectasis Drugs Market share analysis by country, 2022
  • FIGURE Germany Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Bronchiectasis Drugs Market share analysis by country, 2022
  • FIGURE India Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bronchiectasis Drugs Market share analysis by country, 2022
  • FIGURE Brazil Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bronchiectasis Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Bronchiectasis Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1785

REPORT HIGHLIGHT

Bronchiectasis Drugs Market size was valued at USD 481.71 Million in 2022, expanding at a CAGR of 5.1 % from 2023 to 2030.

Pharmaceutical solutions designed for bronchiectasis address the challenges associated with this persistent lung condition, characterized by the inflammation and enlargement of the bronchial tubes. These medications are tailored to alleviate symptoms such as persistent coughing, excessive mucus production, and the susceptibility to recurring lung infections. Treatment typically includes the administration of antibiotics to combat or prevent infections, bronchodilators to expand air passages, and mucolytics to facilitate mucus clearance. The treatment approach is individualized to cater to the specific needs of each patient, with a primary focus on symptom management, infection prevention, and the enhancement of overall lung function, ultimately aiming to enhance the quality of life for those living with bronchiectasis.

Bronchiectasis Drugs Market- Market Dynamics

Rising awareness of this often-underdiagnosed condition propel market demand

Advances in medical knowledge and diagnostic capabilities have led to an uptick in the identification of bronchiectasis cases. Additionally, the aging demographic and the surge in chronic respiratory ailments have heightened the demand for more effective treatment solutions. This increased awareness, along with a growing patient population, has prompted pharmaceutical companies and researchers to allocate resources towards the development of enhanced strategies for managing bronchiectasis. A driving force behind these endeavors is the commitment to improving the well-being of bronchiectasis patients while lessening the burden of recurrent infections and associated symptoms.

Bronchiectasis Drugs Market- Key Insights

In line with the insights provided by our research analyst, the global market for Bronchiectasis Medications is anticipated to experience an approximate annual growth rate of 5.1% throughout the forecast period from 2023 to 2030.

The Bronchiectasis Drugs sector is poised for substantial expansion, primarily driven by the increasing recognition of a medical condition that often goes undetected.

In terms of Drug Class categorization, Antibiotics were forecasted to dominate the market in the year 2022.

When considering the segmentation based on Route of Administration, Oral medications emerged as the leading category in 2022.

Geographically, North America took the lead in revenue generation in 2022.

Bronchiectasis Drugs Market- Segmentation Analysis:

The worldwide market for Bronchiectasis Medications is structured around key factors including Drug Class, Route of Administration, Distribution Channel, and Region.

When it comes to Drug Class categorization, this market is categorized into four distinct segments: Antibiotics, Mucolytics, Bronchodilators, and Anti-inflammatory agents. Notably, Antibiotics take the lead in this classification. Their significance in bronchiectasis therapy lies in their role in managing and preventing the reoccurrence of lung infections, a common complication associated with the condition. Antibiotics are instrumental in targeting and eradicating the microbes responsible for these infections, ultimately leading to improved patient symptoms, lung function, and overall quality of life.

Bronchiectasis Drugs Market- Geographical Insights

From a geographical perspective, this market spans across the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, individual countries play a pivotal role in driving business dynamics.

Several factors have converged to stimulate the heightened demand for bronchiectasis medications in North America. Firstly, the region's aging population is increasingly susceptible to chronic respiratory ailments, including bronchiectasis. Secondly, the advancement of diagnostic expertise and healthcare practitioners' knowledge has led to more precise and timely diagnoses, significantly contributing to the demand for these medications.

Bronchiectasis Drugs Market- Competitive Landscape:

The bronchiectasis pharmaceutical market is distinguished by a limited selection of specialized treatments approved for this condition. Leading pharmaceutical companies offer some of the primary treatment options. Nevertheless, the field is somewhat limited in terms of specialized medications, with therapy predominantly relying on repurposed antibiotics, bronchodilators, and mucolytics. This limitation has created a niche for the development of new drugs, as companies explore innovative therapeutics designed to address the root causes of bronchiectasis and enhance patient outcomes. This presents promising prospects for growth and advancement within the sector.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BRONCHIECTASIS DRUGS MARKET KEY PLAYERS

  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Roche Holding AG
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Sanofi S.A.
  • Sunovion Pharmaceuticals Inc.
  • Mylan N.V.
  • Cipla Ltd.
  • Grifols S.A.
  • Insmed Incorporated
  • Arbor Pharmaceuticals LLC

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY DRUG CLASS

  • Antibiotics
  • Mucolytics
  • Bronchodilators
  • Anti-inflammatory agents

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Inhalation
  • Intravenous

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL BRONCHIECTASIS DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bronchiectasis Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bronchiectasis Drugs Market Snippet by Drug Class
    • 2.1.2. Bronchiectasis Drugs Market Snippet by Route of Administration
    • 2.1.3. Bronchiectasis Drugs Market Snippet by Distribution Channel
    • 2.1.4. Bronchiectasis Drugs Market Snippet by Country
    • 2.1.5. Bronchiectasis Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Bronchiectasis Drugs Key Market Trends

  • 3.1. Bronchiectasis Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bronchiectasis Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bronchiectasis Drugs Market Opportunities
  • 3.4. Bronchiectasis Drugs Market Future Trends

4. Bronchiectasis Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bronchiectasis Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bronchiectasis Drugs Market Landscape

  • 6.1. Bronchiectasis Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bronchiectasis Drugs Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Antibiotics
    • 7.1.3. Mucolytics
    • 7.1.4. Bronchodilators
    • 7.1.5. Anti-inflammatory agents

8. Bronchiectasis Drugs Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Inhalation
    • 8.1.4. Intravenous

9. Bronchiectasis Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies

10. Bronchiectasis Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Bronchiectasis Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Bronchiectasis Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Bronchiectasis Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Bronchiectasis Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Bronchiectasis Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bronchiectasis Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GlaxoSmithKline plc
    • 11.2.2. Novartis AG
    • 11.2.3. Pfizer Inc.
    • 11.2.4. AstraZeneca plc
    • 11.2.5. Boehringer Ingelheim International GmbH
    • 11.2.6. Roche Holding AG
    • 11.2.7. Teva Pharmaceutical Industries Ltd.
    • 11.2.8. Bayer AG
    • 11.2.9. Sanofi S.A.
    • 11.2.10. Sunovion Pharmaceuticals Inc.
    • 11.2.11. Mylan N.V.
    • 11.2.12. Cipla Ltd.
    • 11.2.13. Grifols S.A.
    • 11.2.14. Insmed Incorporated
    • 11.2.15. Arbor Pharmaceuticals LLC

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us